Analysts Set Exova Group Plc (LON:EXO) Target Price at $218.00
Exova Group Plc (LON:EXO) has been assigned an average rating of “Buy” from the six research firms that are presently covering the stock. One analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is GBX 218 ($2.85).
A number of equities research analysts recently commented on the company. Barclays PLC reiterated an “overweight” rating and issued a GBX 225 ($2.94) target price on shares of Exova Group Plc in a research report on Thursday, September 1st. Shore Capital reiterated a “buy” rating on shares of Exova Group Plc in a research report on Thursday, September 22nd. Goldman Sachs Group Inc. decreased their target price on Exova Group Plc from GBX 219 ($2.86) to GBX 210 ($2.74) and set a “buy” rating on the stock in a research report on Thursday, September 1st. Peel Hunt boosted their target price on Exova Group Plc from GBX 170 ($2.22) to GBX 210 ($2.74) and gave the stock an “add” rating in a research report on Wednesday, August 31st. Finally, Credit Suisse Group AG upped their price objective on Exova Group Plc from GBX 200 ($2.61) to GBX 220 ($2.87) and gave the company an “outperform” rating in a research report on Friday, July 8th.
Shares of Exova Group Plc (LON:EXO) opened at 196.00 on Tuesday. The company’s 50 day moving average price is GBX 200.49 and its 200 day moving average price is GBX 181.64. The company’s market capitalization is GBX 490.78 million. Exova Group Plc has a 52-week low of GBX 123.00 and a 52-week high of GBX 210.00.
The firm also recently declared a dividend, which will be paid on Wednesday, November 9th. Stockholders of record on Thursday, October 27th will be issued a GBX 1.05 ($0.01) dividend. The ex-dividend date is Thursday, October 27th. This represents a dividend yield of 0.53%.
About Exova Group Plc
Exova Group plc is a United Kingdom-based provider of testing and advisory services. The Company is a laboratory-based testing company operating approximately 140 laboratories and offices in over 30 countries throughout Europe, the Americas, the Middle East and Asia/Asia Pacific. The Company’s segments include Europe, Americas and Rest of World.
Receive News & Stock Ratings for Exova Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exova Group Plc and related stocks with our FREE daily email newsletter.